Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Pathology|December 16, 2016
Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activationNathan De Beule, Kim De Veirman, Ken Maes, et al.
Cancers|November 24, 2019
The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple MyelomaSylvia Faict, Inge Oudaert, Ludovic D'Auria, et al.
Oncotarget|December 31, 2015
Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cellsSusanne Lub, Anke Maes, Ken Maes, et al.
Cancer Immunology Research|September 15, 2017
Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine SecretionKim De Veirman, Nathan De Beule, Ken Maes, et al.
Molecular Oncology|September 11, 2025
PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolismInge Oudaert, Lauren van den Broecke, Osman Aksoy, et al.
Cancer Letters|November 13, 2018
Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathwayKim De Veirman, Eline Menu, Ken Maes, et al.
Oncotarget|July 11, 2014
The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimeticLiesbeth Bieghs, Susanne Lub, Karel Fostier, et al.
British Journal of Cancer|May 16, 2019
The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphomaAnke Maes, Ken Maes, Hendrik De Raeve, et al.
Blood Cancer Journal|December 18, 2023
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid LeukemiaRong Fan, Hatice Satilmis, Niels Vandewalle, et al.
Cancer Research|December 21, 2017
Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant ProgressionEva De Smedt, Ken Maes, Stefaan Verhulst, et al.
Pageof 5